Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 143

1.

An easy method for preparation of Cre-loxP regulated fluorescent adenoviral expression vectors and its application for direct reprogramming into hepatocytes.

Kurihara C, Nakade K, Pan J, Huang J, Wasylyk B, Obata Y.

Biotechnol Rep (Amst). 2016 Oct 6;12:26-32. doi: 10.1016/j.btre.2016.10.003. eCollection 2016 Dec.

2.

XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice.

Semenchenko K, Wasylyk C, Cheung H, Tourrette Y, Maas P, Schalken JA, van der Pluijm G, Wasylyk B.

PLoS One. 2016 Jul 18;11(7):e0159531. doi: 10.1371/journal.pone.0159531. eCollection 2016.

3.

Endothelial depletion of murine SRF/MRTF provokes intracerebral hemorrhagic stroke.

Weinl C, Castaneda Vega S, Riehle H, Stritt C, Calaminus C, Wolburg H, Mauel S, Breithaupt A, Gruber AD, Wasylyk B, Olson EN, Adams RH, Pichler BJ, Nordheim A.

Proc Natl Acad Sci U S A. 2015 Aug 11;112(32):9914-9. doi: 10.1073/pnas.1509047112. Epub 2015 Jul 28.

4.

Human Papillomavirus-related tumours of the oropharynx display a lower tumour hypoxia signature.

Hanns E, Job S, Coliat P, Wasylyk C, Ramolu L, Pencreach E, Suarez-Carmona M, Herfs M, Ledrappier S, Macabre C, Abecassis J, Wasylyk B, Jung AC.

Oral Oncol. 2015 Sep;51(9):848-56. doi: 10.1016/j.oraloncology.2015.06.003. Epub 2015 Jun 27.

PMID:
26121938
5.

The oncogenic MicroRNA Hsa-miR-155-5p targets the transcription factor ELK3 and links it to the hypoxia response.

Robertson ED, Wasylyk C, Ye T, Jung AC, Wasylyk B.

PLoS One. 2014 Nov 17;9(11):e113050. doi: 10.1371/journal.pone.0113050. eCollection 2014.

6.

Elk3 deficiency causes transient impairment in post-natal retinal vascular development and formation of tortuous arteries in adult murine retinae.

Weinl C, Wasylyk C, Garcia Garrido M, Sothilingam V, Beck SC, Riehle H, Stritt C, Roux MJ, Seeliger MW, Wasylyk B, Nordheim A.

PLoS One. 2014 Sep 9;9(9):e107048. doi: 10.1371/journal.pone.0107048. eCollection 2014.

7.

Crosstalk between Mdm2, p53 and HIF1-α: distinct responses to oxygen stress and implications for tumour hypoxia.

Robertson ED, Semenchenko K, Wasylyk B.

Subcell Biochem. 2014;85:199-214. doi: 10.1007/978-94-017-9211-0_11. Review.

PMID:
25201196
8.

Identification of clinically relevant HPV-related HNSCC: in p16 should we trust?

Wasylyk B, Abecassis J, Jung AC.

Oral Oncol. 2013 Oct;49(10):e33-7. doi: 10.1016/j.oraloncology.2013.07.014. Epub 2013 Aug 17. Review. No abstract available.

PMID:
23962789
9.

A poor prognosis subtype of HNSCC is consistently observed across methylome, transcriptome, and miRNome analysis.

Jung AC, Job S, Ledrappier S, Macabre C, Abecassis J, de Reyniès A, Wasylyk B.

Clin Cancer Res. 2013 Aug 1;19(15):4174-84. doi: 10.1158/1078-0432.CCR-12-3690. Epub 2013 Jun 11.

10.

Tubulin tyrosine ligase like 12, a TTLL family member with SET- and TTL-like domains and roles in histone and tubulin modifications and mitosis.

Brants J, Semenchenko K, Wasylyk C, Robert A, Carles A, Zambrano A, Pradeau-Aubreton K, Birck C, Schalken JA, Poch O, de Mey J, Wasylyk B.

PLoS One. 2012;7(12):e51258. doi: 10.1371/journal.pone.0051258. Epub 2012 Dec 12.

11.

The NEDD8 conjugation pathway regulates p53 transcriptional activity and head and neck cancer cell sensitivity to ionizing radiation.

Guihard S, Ramolu L, Macabre C, Wasylyk B, Noël G, Abecassis J, Jung AC.

Int J Oncol. 2012 Oct;41(4):1531-40. doi: 10.3892/ijo.2012.1584. Epub 2012 Aug 7.

PMID:
22895816
12.

CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.

Jung AC, Guihard S, Krugell S, Ledrappier S, Brochot A, Dalstein V, Job S, de Reynies A, Noël G, Wasylyk B, Clavel C, Abecassis J.

Int J Cancer. 2013 Jan 15;132(2):E26-36. doi: 10.1002/ijc.27776. Epub 2012 Sep 1.

13.

c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells.

Chen J, Sun WL, Wasylyk B, Wang YP, Zheng H.

Anticancer Drugs. 2012 Jan;23(1):98-107. doi: 10.1097/CAD.0b013e32834bc978.

PMID:
21968419
14.

A review of post-translational modifications and subcellular localization of Ets transcription factors: possible connection with cancer and involvement in the hypoxic response.

Charlot C, Dubois-Pot H, Serchov T, Tourrette Y, Wasylyk B.

Methods Mol Biol. 2010;647:3-30. doi: 10.1007/978-1-60761-738-9_1. Review.

PMID:
20694658
15.

ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.

Ayoub C, Wasylyk C, Li Y, Thomas E, Marisa L, Robé A, Roux M, Abecassis J, de Reyniès A, Wasylyk B.

Br J Cancer. 2010 Aug 24;103(5):715-26. doi: 10.1038/sj.bjc.6605823. Epub 2010 Jul 27.

16.

Ternary complex factors SAP-1 and Elk-1, but not net, are functionally equivalent in thymocyte development.

Costello P, Nicolas R, Willoughby J, Wasylyk B, Nordheim A, Treisman R.

J Immunol. 2010 Jul 15;185(2):1082-92. doi: 10.4049/jimmunol.1000472. Epub 2010 Jun 16.

17.

Epigenetic regulation of p16Ink4a and Arf by JDP2 in cellular senescence.

Nakade K, Wasylyk B, Yokoyama KK.

Biomol Concepts. 2010 May 1;1(1):49-58. doi: 10.1515/bmc.2010.008.

PMID:
25961985
18.

Involvement of net and Hif1alpha in distinct yet intricately linked hypoxia-induced signaling pathways.

Serchov T, Dubois-Pot-Schneider H, Charlot C, Rösl F, Wasylyk B.

J Biol Chem. 2010 Jul 9;285(28):21223-32. doi: 10.1074/jbc.M110.121723. Epub 2010 Apr 28.

19.

Regulation of MCP-1 chemokine transcription by p53.

Hacke K, Rincon-Orozco B, Buchwalter G, Siehler SY, Wasylyk B, Wiesmüller L, Rösl F.

Mol Cancer. 2010 Apr 20;9:82. doi: 10.1186/1476-4598-9-82.

20.

The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage.

Kerr N, Pintzas A, Holmes F, Hobson SA, Pope R, Wallace M, Wasylyk C, Wasylyk B, Wynick D.

Mol Cell Neurosci. 2010 Jun;44(2):165-77. doi: 10.1016/j.mcn.2010.03.005. Epub 2010 Mar 18.

21.

Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.

Wasylyk C, Zambrano A, Zhao C, Brants J, Abecassis J, Schalken JA, Rogatsch H, Schaefer G, Pycha A, Klocker H, Wasylyk B.

Int J Cancer. 2010 Dec 1;127(11):2542-53. doi: 10.1002/ijc.25261.

22.

Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma.

Jung AC, Briolat J, Millon R, de Reyniès A, Rickman D, Thomas E, Abecassis J, Clavel C, Wasylyk B.

Int J Cancer. 2010 Apr 15;126(8):1882-1894. doi: 10.1002/ijc.24911.

23.

Complexity in transcription control at the activation domain-mediator interface.

Balamotis MA, Pennella MA, Stevens JL, Wasylyk B, Belmont AS, Berk AJ.

Sci Signal. 2009 May 5;2(69):ra20. doi: 10.1126/scisignal.1164302. Erratum in: Sci Signal. 2009 Sep 22;2(89):er8.

24.

CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.

Ganguli-Indra G, Wasylyk C, Liang X, Millon R, Leid M, Wasylyk B, Abecassis J, Indra AK.

PLoS One. 2009;4(4):e5367. doi: 10.1371/journal.pone.0005367. Epub 2009 Apr 28. Erratum in: PLoS One. 2009;4(4). doi: 10.1371/annotation/b01c646f-14c7-4aac-8812-9ed4f847c857. Indra, Arup [corrected to Indra, Arup K].

25.

JDP2 (Jun Dimerization Protein 2)-deficient mouse embryonic fibroblasts are resistant to replicative senescence.

Nakade K, Pan J, Yamasaki T, Murata T, Wasylyk B, Yokoyama KK.

J Biol Chem. 2009 Apr 17;284(16):10808-17. doi: 10.1074/jbc.M808333200. Epub 2009 Feb 20.

26.

Prediction of future metastasis and molecular characterization of head and neck squamous-cell carcinoma based on transcriptome and genome analysis by microarrays.

Rickman DS, Millon R, De Reynies A, Thomas E, Wasylyk C, Muller D, Abecassis J, Wasylyk B.

Oncogene. 2008 Nov 20;27(51):6607-22. doi: 10.1038/onc.2008.251. Epub 2008 Aug 4.

PMID:
18679425
27.

Inhibition of the Ras-Net (Elk-3) pathway by a novel pyrazole that affects microtubules.

Wasylyk C, Zheng H, Castell C, Debussche L, Multon MC, Wasylyk B.

Cancer Res. 2008 Mar 1;68(5):1275-83. doi: 10.1158/0008-5472.CAN-07-2674.

28.

High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara.

Hebben M, Brants J, Birck C, Samama JP, Wasylyk B, Spehner D, Pradeau K, Domi A, Moss B, Schultz P, Drillien R.

Protein Expr Purif. 2007 Dec;56(2):269-78. Epub 2007 Aug 24.

PMID:
17892951
29.

The ternary complex factor Net/Elk-3 participates in the transcriptional response to hypoxia and regulates HIF-1 alpha.

Gross C, Dubois-Pot H, Wasylyk B.

Oncogene. 2008 Feb 21;27(9):1333-41. Epub 2007 Aug 20.

PMID:
17704799
30.

The ternary complex factor net is downregulated by hypoxia and regulates hypoxia-responsive genes.

Gross C, Buchwalter G, Dubois-Pot H, Cler E, Zheng H, Wasylyk B.

Mol Cell Biol. 2007 Jun;27(11):4133-41. Epub 2007 Apr 2.

31.

A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH.

Wicker N, Carles A, Mills IG, Wolf M, Veerakumarasivam A, Edgren H, Boileau F, Wasylyk B, Schalken JA, Neal DE, Kallioniemi O, Poch O.

BMC Genomics. 2007 Mar 29;8:84.

32.

Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma.

Muller D, Millon R, Théobald S, Hussenet T, Wasylyk B, du Manoir S, Abecassis J.

Br J Cancer. 2006 Apr 10;94(7):1041-4.

33.

hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.

Kogan I, Goldfinger N, Milyavsky M, Cohen M, Shats I, Dobler G, Klocker H, Wasylyk B, Voller M, Aalders T, Schalken JA, Oren M, Rotter V.

Cancer Res. 2006 Apr 1;66(7):3531-40.

34.

The ternary complex factor Net regulates cell migration through inhibition of PAI-1 expression.

Buchwalter G, Gross C, Wasylyk B.

Mol Cell Biol. 2005 Dec;25(24):10853-62.

35.

Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours.

Seghatoleslam A, Zambrano A, Millon R, Ganguli G, Argentini M, Cromer A, Abecassis J, Wasylyk B.

Biochem Biophys Res Commun. 2006 Jan 6;339(1):422-9. Epub 2005 Nov 14.

PMID:
16300736
36.

Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display.

Carles A, Millon R, Cromer A, Ganguli G, Lemaire F, Young J, Wasylyk C, Muller D, Schultz I, Rabouel Y, Dembélé D, Zhao C, Marchal P, Ducray C, Bracco L, Abecassis J, Poch O, Wasylyk B.

Oncogene. 2006 Mar 16;25(12):1821-31.

PMID:
16261155
37.
38.

Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells.

van Riggelen J, Buchwalter G, Soto U, De-Castro Arce J, zur Hausen H, Wasylyk B, Rösl F.

J Biol Chem. 2005 Feb 4;280(5):3286-94. Epub 2004 Nov 16.

40.

Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma.

Lemaire F, Millon R, Muller D, Rabouel Y, Bracco L, Abecassis J, Wasylyk B.

Br J Cancer. 2004 Jul 19;91(2):258-61.

41.

Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter.

Fiucci G, Beaucourt S, Duflaut D, Lespagnol A, Stumptner-Cuvelette P, Géant A, Buchwalter G, Tuynder M, Susini L, Lassalle JM, Wasylyk C, Wasylyk B, Oren M, Amson R, Telerman A.

Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3510-5. Epub 2004 Feb 25.

42.

The tumor suppressor p53 inhibits Net, an effector of Ras/extracellular signal-regulated kinase signaling.

Nakade K, Zheng H, Ganguli G, Buchwalter G, Gross C, Wasylyk B.

Mol Cell Biol. 2004 Feb;24(3):1132-42.

43.

p53-independent functions of MDM2.

Ganguli G, Wasylyk B.

Mol Cancer Res. 2003 Dec;1(14):1027-35. Review.

44.

Ets ternary complex transcription factors.

Buchwalter G, Gross C, Wasylyk B.

Gene. 2004 Jan 7;324:1-14. Review.

PMID:
14693367
45.

Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis.

Cromer A, Carles A, Millon R, Ganguli G, Chalmel F, Lemaire F, Young J, Dembélé D, Thibault C, Muller D, Poch O, Abecassis J, Wasylyk B.

Oncogene. 2004 Apr 1;23(14):2484-98.

PMID:
14676830
46.

Differential expression profiling of head and neck squamous cell carcinoma (HNSCC).

Lemaire F, Millon R, Young J, Cromer A, Wasylyk C, Schultz I, Muller D, Marchal P, Zhao C, Melle D, Bracco L, Abecassis J, Wasylyk B.

Br J Cancer. 2003 Nov 17;89(10):1940-9.

47.

The transcription factor Net regulates the angiogenic switch.

Zheng H, Wasylyk C, Ayadi A, Abecassis J, Schalken JA, Rogatsch H, Wernert N, Maira SM, Multon MC, Wasylyk B.

Genes Dev. 2003 Sep 15;17(18):2283-97.

48.

BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination.

Sengupta S, Linke SP, Pedeux R, Yang Q, Farnsworth J, Garfield SH, Valerie K, Shay JW, Ellis NA, Wasylyk B, Harris CC.

EMBO J. 2003 Mar 3;22(5):1210-22.

49.

The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif.

Deltour S, Pinte S, Guerardel C, Wasylyk B, Leprince D.

Mol Cell Biol. 2002 Jul;22(13):4890-901.

50.

The p53 tumour suppressor inhibits glucocorticoid-induced proliferation of erythroid progenitors.

Ganguli G, Back J, Sengupta S, Wasylyk B.

EMBO Rep. 2002 Jun;3(6):569-74. Epub 2002 May 24.

Supplemental Content

Loading ...
Support Center